Skandinaviska Enskilda Banken AB »

Eyepoint Pharmaceuticals shares owned by Skandinaviska Enskilda Banken AB

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Skandinaviska Enskilda Banken AB from 13F filings

Historical chart of Skandinaviska Enskilda Banken AB investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Skandinaviska Enskilda Banken AB

Quarter filed Position value Share count Share price at filing
2024-09-30 $571k 72k 7.99
2024-03-31 $5.8M 283k 20.67

More positions owned by Skandinaviska Enskilda Banken AB

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Abbvie (ABBV)
Merck & Co (MRK)
Tesla Motors (TSLA)

View all positions for Skandinaviska Enskilda Banken AB

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
BlackRock
Franklin Resources
BlackRock
Vanguard Group
T. Rowe Price Associates
Morgan Stanley
Federated Investors
Citadel Advisors
Patient Square Capital
T. Rowe Price Investment Management
State Street Corporation
Geode Capital Management
Octagon Capital Advisors

View all funds holding Eyepoint Pharmaceuticals